US3124505A
(en)
*
|
|
1964-03-10 |
|
Aerosol concentrates containing a sta- |
US3155573A
(en)
*
|
1958-05-06 |
1964-11-03 |
Benger Lab Ltd |
Inhalant composition and method of making same
|
US3076745A
(en)
*
|
1958-11-17 |
1963-02-05 |
Poultry Service And Res Corp |
Antibiotic method for promoting poultry growth
|
US3079299A
(en)
*
|
1959-11-16 |
1963-02-26 |
Gen Aerosol Corp |
Self-propelling medicinal ointment composition containing polyethylene and method ofapplication
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
DE1170909B
(de)
*
|
1961-02-17 |
1964-05-27 |
Specialties Dev Corp |
Selbsttreibendes Gemisch
|
US3135658A
(en)
*
|
1961-10-10 |
1964-06-02 |
Merck & Co Inc |
Non-aqueous oleaginous aerosol foam therapy of bovine mastitis
|
US3095355A
(en)
*
|
1961-10-12 |
1963-06-25 |
Revlon |
Aerosol composition
|
GB1013386A
(tr)
*
|
1962-05-01 |
|
|
|
BE632504A
(tr)
*
|
1962-05-24 |
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
BE629985A
(tr)
*
|
1962-11-29 |
|
|
|
US3345295A
(en)
*
|
1963-02-13 |
1967-10-03 |
Shulton Inc |
Copper cleaning compositions
|
US3304230A
(en)
*
|
1963-02-18 |
1967-02-14 |
Revlon |
Liquid aerosol propellant solutions of fatty acid salts of physiologically active amines
|
US3446892A
(en)
*
|
1963-09-18 |
1969-05-27 |
Whitmire Research Lab Inc |
Immobilizing insects by sudden reduction of body temperature
|
US3260408A
(en)
*
|
1964-04-08 |
1966-07-12 |
Bell & Howell Co |
Method and means of dispersing particulate material in a stream of carrier fluid
|
US3282791A
(en)
*
|
1965-08-17 |
1966-11-01 |
Merck & Co Inc |
Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
|
US3968203A
(en)
*
|
1965-10-01 |
1976-07-06 |
Jerome G. Spitzer |
Aerosol astringent composition
|
US3402665A
(en)
*
|
1966-08-15 |
1968-09-24 |
Aeroprojects Inc |
Nonpyrotechnic disseminator
|
US4027007A
(en)
*
|
1970-12-09 |
1977-05-31 |
Colgate-Palmolive Company |
Antiperspirants formulated with borax
|
GB1429184A
(en)
*
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4411883A
(en)
*
|
1973-02-05 |
1983-10-25 |
Colgate-Palmolive Company |
Antiperspirant
|
US3923971A
(en)
*
|
1973-09-13 |
1975-12-02 |
Alexandre Seilinger |
Antiperspirant and deodorant composition containing lamellar substances
|
US4010252A
(en)
*
|
1974-12-19 |
1977-03-01 |
Colgate-Palmolive Company |
Antimicrobial compositions
|
US4192766A
(en)
*
|
1975-04-25 |
1980-03-11 |
United Chemical Corporation |
Composition for decreasing water resistance to movement
|
FI770215A
(tr)
*
|
1976-01-30 |
1977-07-31 |
Fisons Ltd |
|
US4147766A
(en)
*
|
1976-06-09 |
1979-04-03 |
Armour Pharmaceutical Company |
Macrospherical particles of anti-perspirants
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
DE2804931A1
(de)
*
|
1978-02-06 |
1979-08-16 |
Fresenius Chem Pharm Ind |
Metallsulfadiazine in feinteiliger form
|
JPS5529524A
(en)
*
|
1978-08-21 |
1980-03-01 |
Toyo Aerosol Kogyo Kk |
Powdery aerosol composition
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
CA1178889A
(en)
*
|
1980-08-28 |
1984-12-04 |
Kenneth S. Su |
Intranasal formulation
|
JPS59163313A
(ja)
*
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
DE3326089A1
(de)
*
|
1983-07-20 |
1985-02-07 |
Gödecke AG, 1000 Berlin |
Zur inhalation bestimmte darreichungsform von calcium-antagonisten
|
US4581225A
(en)
*
|
1984-04-25 |
1986-04-08 |
Eli Lilly And Company |
Sustained release intranasal formulation and method of use thereof
|
ZA852884B
(en)
*
|
1984-04-25 |
1986-11-26 |
Lilly Co Eli |
Sustained release intranasal formulation and method of use thereof
|
GB8828477D0
(en)
|
1988-12-06 |
1989-01-05 |
Riker Laboratories Inc |
Medical aerosol formulations
|
US5776434A
(en)
|
1988-12-06 |
1998-07-07 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
AU5194990A
(en)
*
|
1989-02-23 |
1990-09-26 |
Rorer International (Holdings), Inc. |
Therapeutic aerosol formulations
|
GB8921222D0
(en)
*
|
1989-09-20 |
1989-11-08 |
Riker Laboratories Inc |
Medicinal aerosol formulations
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
HU205249B
(en)
*
|
1990-11-09 |
1992-04-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing suspensive aerosole composition
|
RU2054180C1
(ru)
*
|
1991-08-21 |
1996-02-10 |
Жирнов Олег Петрович (н/п) |
Способ лечения вирусных респираторных инфекций
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
EP0616525B1
(en)
*
|
1991-12-12 |
1995-09-27 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation
|
CA2381329C
(en)
*
|
1991-12-12 |
2003-04-15 |
Glaxo Group Limited |
Medicaments
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
DE69233319T2
(de)
|
1991-12-18 |
2005-02-17 |
Minnesota Mining & Manufacturing Company, St. Paul |
Aerosolzusammensetzungen für Arzneimittelsuspensionen
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US5756071A
(en)
*
|
1992-06-03 |
1998-05-26 |
Arrowdean Limited |
Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
|
US5368842A
(en)
*
|
1992-10-29 |
1994-11-29 |
The Gillette Company |
High efficacy aerosol antiperspirant composition
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
PL320856A1
(en)
|
1994-12-22 |
1997-11-10 |
Astra Ab |
Aerosol drug preparations
|
AU703532B2
(en)
*
|
1994-12-22 |
1999-03-25 |
Astra Aktiebolag |
Therapeutic preparation for inhalation containing parathyroid hormone, PTH
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
CA2280099C
(en)
|
1997-02-05 |
2005-12-27 |
Jago Pharma Ag |
Medical aerosol formulations
|
US6946117B1
(en)
*
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20010006939A1
(en)
*
|
1997-10-03 |
2001-07-05 |
Ralph W. Niven |
Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
|
US6451285B2
(en)
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
ES2234266T3
(es)
|
1998-07-24 |
2005-06-16 |
Jago Research Ag |
Formulaciones medicas para aerosoles.
|
DE59904648D1
(de)
|
1998-08-04 |
2003-04-24 |
Jago Res Ag Muttenz |
Medizinische aerosolformulierungen
|
US6290930B1
(en)
|
1998-12-18 |
2001-09-18 |
Baker Norton Pharmaceuticals, Inc. |
Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
ATE404186T1
(de)
*
|
2004-10-12 |
2008-08-15 |
Generics Uk Ltd |
Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
|
EP1949891A1
(en)
|
2004-10-12 |
2008-07-30 |
Generics (UK) Limited |
Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
KR101488403B1
(ko)
|
2005-05-18 |
2015-02-04 |
엠펙스 파마슈티컬즈, 인코포레이티드 |
에어로졸화된 플루오로퀴놀론 및 이의 용도
|
US8367734B1
(en)
|
2005-08-11 |
2013-02-05 |
Amphastar Pharmaceuticals Inc. |
Stable epinephrine suspension formulation with high inhalation delivery efficiency
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
GB0620700D0
(en)
|
2006-10-19 |
2006-11-29 |
3M Innovative Properties Co |
Metered dose valves and dispensers
|
PL2425820T3
(pl)
|
2007-02-11 |
2015-08-31 |
Map Pharmaceuticals Inc |
Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
|
SI2346509T1
(sl)
|
2008-10-07 |
2020-08-31 |
Horizon Orphan Llc |
Inhalacija levofloksacina za zmanjšanje vnetja pljuč
|
NZ592717A
(en)
|
2008-10-07 |
2013-03-28 |
Mpex Pharmaceuticals Inc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation
|
RU2563809C2
(ru)
|
2009-09-04 |
2015-09-20 |
Мпекс Фармасьютикалс, Инк. |
Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
|
ES2913095T3
(es)
|
2011-01-31 |
2022-05-31 |
Avalyn Pharma Inc |
Compuestos de pirfenidona y análogos de piridona en aerosol y usos de los mismos
|
GB201118188D0
(en)
|
2011-10-21 |
2011-12-07 |
3M Innovative Properties Co |
Manufacture of medicinal aerosol canisters
|
GB201210580D0
(en)
|
2012-06-14 |
2012-08-01 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
GB201221063D0
(en)
|
2012-11-23 |
2013-01-09 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
WO2015017728A1
(en)
|
2013-07-31 |
2015-02-05 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
AU2015204558B2
(en)
|
2014-01-10 |
2020-04-30 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
GB2604314A
(en)
|
2017-09-22 |
2022-09-07 |
Nerudia Ltd |
Device, system and method
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|